Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Screening for compounds that modulate GPR3-mediated beta-arrestin signaling and amyloid beta peptide generation

Screening for compounds that modulate GPR3-mediated beta-arrestin signaling and amyloid beta peptide generation

US Patent 8580493 · Granted Nov 12, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Γ-secretase stabilizing compound screening assay2022
Therapeutic agents for neurological and psychiatric disorders2020
Single domain antibodies capable of modulating BACE activity2019
Single domain antibodies capable of modulating BACE activity2018
Restoring phosphorylation of a novel PINK1 substrate to treat parkinson's diseas2018
BACE1 inhibitory antibodies2015
Screening methods for compounds that modulate ARF-6 mediated endosomal redistrib2014
Single domain antibodies capable of modulating BACE activity2013
Binding domains between presenilins and their substrates as targets for drug scr2007